Trek Financial, LLC Gilead Sciences, Inc. Transaction History

Trek Financial, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$63.15 - $72.88 $80,768 - $93,213	-1,279 Reduced 22.79%	4,332 $297,000
Q1 2024 May 14, 2024	SELL	$71.58 - $87.29 $103,218 - $125,872	-1,442 Reduced 20.45%	5,611 $411,000
Q4 2023 Feb 08, 2024	SELL	$73.27 - $83.09 $110,491 - $125,299	-1,508 Reduced 17.61%	7,053 $571,000
Q3 2023 Nov 14, 2023	SELL	$73.94 - $80.67 $22,403 - $24,443	-303 Reduced 3.42%	8,561 $641,000
Q2 2023 Aug 11, 2023	SELL	$76.01 - $86.7 $82,014 - $93,549	-1,079 Reduced 10.85%	8,864 $683,000
Q1 2023 May 12, 2023	BUY	$77.31 - $88.08 $255,509 - $291,104	3,305 Added 49.79%	9,943 $824,000
Q4 2022 Feb 13, 2023	SELL	$62.32 - $89.47 $7,914 - $11,362	-127 Reduced 1.88%	6,638 $569,000
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $306,035 - $349,571	-5,140 Reduced 43.18%	6,765 $417,000
Q2 2022 Aug 10, 2022	BUY	$57.72 - $65.01 $2,020 - $2,275	35 Added 0.29%	11,905 $736,000
Q1 2022 May 10, 2022	BUY	$57.92 - $72.58 $134,953 - $169,111	2,330 Added 24.42%	11,870 $706,000
Q4 2021 Jan 19, 2022	BUY	$64.88 - $73.64 $618,955 - $702,525	9,540 New	9,540 $693,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Trek Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Trek Financial, LLC with notifications on news.